Literature DB >> 8647637

Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong.

S T Cheung, K W Lo, S F Leung, W Y Chan, P H Choi, P J Johnson, J C Lee, D P Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8647637     DOI： 10.1002/(SICI)1097-0215(19960529)66:5<711::AID-IJC21>3.0.CO;2-5

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  14 in total

1.  Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.

Authors:  K Sandvej; B S Andresen; X G Zhou; N Gregersen; S Hamilton-Dutoit
Journal:  Mol Pathol       Date:  2000-10

2.  Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.

Authors:  Mu-Sheng Zeng; Da-Jiang Li; Qing-Lun Liu; Li-Bing Song; Man-Zhi Li; Ru-Hua Zhang; Xing-Juan Yu; Hui-Min Wang; Ingemar Ernberg; Yi-Xin Zeng
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.

Authors:  Jun Zhang; Lin Jia; Weitao Lin; Yim Ling Yip; Kwok Wai Lo; Victoria Ming Yi Lau; Dandan Zhu; Chi Man Tsang; Yuan Zhou; Wen Deng; Hong Lok Lung; Maria Li Lung; Lai Man Cheung; Sai Wah Tsao
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.

Authors:  K Hayashi; W G Chen; Y Y Chen; I Murakami; H L Chen; N Ohara; S Nose; K Hamaya; S Matsui; M M Bacchi; C E Bacchi; K L Chang; L M Weiss
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 5.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

6.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.

Authors:  Hiroshi Uozaki; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1.

Authors:  Jun Wan; Luguo Sun; Jennifer Woo Mendoza; Yiu Loon Chui; Dolly P Huang; Zhijian J Chen; Nobutaka Suzuki; Shinobu Suzuki; Wen-Chen Yeh; Shizuo Akira; Kunihiro Matsumoto; Zheng-Gang Liu; Zhenguo Wu
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.

Authors:  Kimberly D Erickson; Christoph Berger; William F Coffin; Edwin Schiff; Dennis M Walling; Jennifer M Martin
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Authors:  Ilona Argirion; Katie R Zarins; Julie J Ruterbusch; Patravoot Vatanasapt; Hutcha Sriplung; Erlene K Seymour; Laura S Rozek
Journal:  Cancer       Date:  2019-09-16       Impact factor: 6.860

10.  Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation.

Authors:  Wen Deng; Pei Shin Pang; Chi Man Tsang; Pok Man Hau; Yim Ling Yip; Annie L M Cheung; Sai Wah Tsao
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.